Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|12|23|2867-2873
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.12, Iss.23, 2006-08, pp. : 2867-2873
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Hepatic ischemia/reperfusion injury is a complication of liver resection surgery, transplantation and hypovolemic shock, leading to local and remote cellular damage and organ dysfunction. This injury is largely a result of an acute inflammatory response characterized by the induction of a cascade of proinflammatory mediators that culminates in the recruitment of leukocytes to the post-ischemic tissue leading to parenchymal cell injury. Endogenous regulatory mechanisms exist to attempt to control this inflammatory response. These include anti-inflammatory cytokines that function to suppress proinflammatory mediator expression. In this review, we address the current knowledge of the pro- and anti-inflammatory cytokine components of the acute liver inflammatory response to ischemia/reperfusion as well as how these cytokines can be manipulated to reduce post-ischemic liver injury.
Related content
The Role of Glycine in Hepatic Ischemia-Reperfusion Injury
Current Pharmaceutical Design, Vol. 12, Iss. 23, 2006-08 ,pp. :
Access to resources
Recommend
By Pappo Orit Ben-Ari Ziv Shevtsov Evgeni Avlas Orna Gassmann Max Ravid Amiram Cheporko Yelena Hochhauser Edith
Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 12, 2010-12 ,pp. :
The Role of Prostaglandins in Liver Ischemia-Reperfusion Injury
Current Pharmaceutical Design, Vol. 12, Iss. 23, 2006-08 ,pp. :